PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17234795-0	2007	Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis.	Azoxymethane	95-107	epidermal growth factor receptor	Mus musculus	0-32	
17234795-4	2007	In the current study, we used a specific EGFR antagonist, gefitinib, to investigate this role of the receptor in azoxymethane colonic premalignancy.	Azoxymethane	113-125	epidermal growth factor receptor	Mus musculus	41-45	
17234795-10	2007	Azoxymethane significantly induced pro-transforming growth factor-alpha (6.4+/-1.3-fold) and increased phospho-(active) EGFR (5.9+/-1.1-fold), phospho-(active) ErbB2 (2.3+/-0.2-fold), and phospho-(active) extracellular signal-regulated kinase (3.3+/-0.4-fold) in premalignant colonocytes.	Azoxymethane	0-12	epidermal growth factor receptor	Mus musculus	120-124